Norah Shire

Norah Shire currently serves as Vice President and Global Medical Head for the GU/GYN Franchise at AstraZeneca, where responsibilities also include acting as Global Program Lead and Global Clinical Program Lead for IO mNSC. Previous experience includes roles in Translational Medicine at MedImmune and various clinical leadership positions at Merck, including Clinical Director and Director of Clinical Monitoring. Norah Shire began a career in research as a Research Associate and later as a Research Assistant Professor at the University of Cincinnati, demonstrating a strong foundation in both clinical and translational research.